INVITRO SUSCEPTIBILITIES OF MYCOPLASMA-PNEUMONIAE, MYCOPLASMA-HOMINIS, AND UREAPLASMA-UREALYTICUM TO SPARFLOXACIN AND PD-127391

被引:50
作者
WAITES, KB
DUFFY, LB
SCHMID, T
CRABB, D
PATE, MS
CASSELL, GH
机构
[1] UNIV ALABAMA,SCH MED,DEPT MICROBIOL,BIRMINGHAM,AL 35294
[2] UNIV ALABAMA,SCH DENT,DEPT MICROBIOL,BIRMINGHAM,AL 35294
关键词
D O I
10.1128/AAC.35.6.1181
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The in vitro activities of two investigational quinolones, sparfloxacin (previously designated AT 4140) and PD 127391, were determined for 30 strains each of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum and compared with those of ciprofloxacin, tetracycline, clindamycin, and erythromycin. Erythromycin was the most active compound against M. pneumoniae (maximum MIC, < 0.008-mu-g/ml). PD 127391 (MICs, < 0.008 to 0.031-mu-g/ml), sparfloxacin (MICs, < 0.008 to 0.25-mu-g/ml), clindamycin (MICs < 0.008 to 0.5-mu-g/ml), and tetracycline (MICs, 0.063 to 0.25-mu-g/ml) were superior to ciprofloxacin (MICs, 0.5 to 2-mu-g/ml). Sparfloxacin and PD 127391 were active against M. hominis (MICs, < 0.008 to 0.031-mu-g/ml for each) at concentrations comparable to those of clindamycin (MICs, < 0.008 to 0.063-mu-g/ml) and at concentrations lower than those of ciprofloxacin (MICs, 0.125 to 0.5-mu-g/ml). As expected, M. hominis was resistant to erythromycin (MICs, 32 to greater-than-or-equal-to 256-mu-g/ml). For U. urealyticum, PD 127391 (MICs, 0.031 to 0.5-mu-g/ml) and sparfloxacin (MICs, 0.063 to 1-mu-g/ml) were superior to erythromycin (MICs, 0.25 to 4-mu-g/ml), ciprofloxacin (MICs, 0.5 to 8-mu-g/ml), and clindamycin (MICs, 0.25 to 64-mu-g/ml. Both new quinolones were equally active against tetracycline-susceptible as well as -resistant strains of M. hominis and U. urealyticum. The possible influence of medium components and/or pH on MICs was evaluated by testing a Staphylococcus aureus reference strain with each antibiotic in SP-4 broth and 10-B broth and comparing the results with published MICs for this strain. MICs determined in 10-B broth for erythromycin were affected most. This study shows that the activities of sparfloxacin and PD 127391 are similar to one another and comparable or superior to those of other drugs used to treat mycoplasmal infections. The MICs of both new quinolones were consistently 2 to several dilutions lower than those of ciprofloxacin for each species.
引用
收藏
页码:1181 / 1185
页数:5
相关论文
共 46 条
[1]   ACTIVITIES OF NEW QUINOLINE DERIVATIVES AGAINST GENITAL PATHOGENS [J].
AZNAR, J ;
CABALLERO, MC ;
LOZANO, MC ;
DEMIGUEL, C ;
PALOMARES, JC ;
PEREA, EJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (01) :76-78
[2]  
CANTET P, 1983, PATHOL BIOL, V31, P501
[3]  
CASSELL GH, 1988, LANCET, V2, P240
[4]  
CASSELL GH, 1988, PEDIATR INFECT DIS J, V7, P535
[5]   COMPARATIVE SUSCEPTIBILITY OF MYCOPLASMA-PNEUMONIAE TO ERYTHROMYCIN, CIPROFLOXACIN, AND LOMEFLOXACIN [J].
CASSELL, GH ;
WAITES, KB ;
PATE, MS ;
CANUPP, KC ;
DUFFY, LB .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1989, 12 (05) :433-435
[6]  
CASSELL GH, 1990, 30TH INT C ANT AG CH
[7]  
Cassell GH., 1985, MYCOPLASMAS MYCOPLAS, V4, P65, DOI [10.1016/B978-0-12-078404-2.50010-5, DOI 10.1016/B978-0-12-078404-2.50010-5]
[8]  
CASSELL GH, 1987, ADV EXP MED BIOL, V24, P93
[9]  
CHOW AW, 1984, ANTIMICROBIAL THERAP, P209
[10]   INCREASE IN RESISTANCE OF MYCOPLASMA-HOMINIS TO TETRACYCLINES [J].
CUMMINGS, MC ;
MCCORMACK, WM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (12) :2297-2299